Categories Earnings, Technology
Comcast (CMCSA) picks up momentum as Xumo buyout talks spur optimism
Comcast’s (NASDAQ: CMCSA) ongoing rally gathered steam amid reports of the company pursuing the acquisition of streaming service Xumo. The stock traded higher during Monday’s session, a week after media reports said the management was in advanced talks to acquire the video streaming app.
While the market is generally bullish about the expansion program that focuses on buyouts, there is skepticism over the monetization prospects of such deals. After closing a series of acquisitions during the early part of the year, the company last quarter recorded a decline in the contributions from Sky, the UK-based broadcaster that joined the Comcast fold last year.
Mixed View
Meanwhile, a section of market watchers, like Benchmark, see merit in that strategy. According to Benchmark, acquiring Xumo would add to the prospects of the company’s upcoming streaming service Peacock, which will be rolled out in April next year. The brokerage also reaffirmed its buy rating on the stock. Xumo, owned by Panasonic and Meredith, has more than five million active users.
The management is expected to provide updates on the Peacock launch at next month’s investor meet. The new service will be run by the company’s subsidiary NBCUniversal. The launch is termed as a strategic move by Comcast to make inroads into the lucrative streaming space, which is the new fad among telecommunication companies.
Peacock in Focus
In the third quarter, both earnings and revenues increased from last year and exceeded expectations. The event was closely followed by investors as it was the first quarterly report after Comcast announced Peacock.
Also see: Comcast Q3 2019 Earnings Conference Call Transcript
After climbing to a record high a few months ago, Comcast’s stock retreated and reached the pre-boom levels earlier this month. However, the shares regained strength since then and closed the last trading session slightly above $45.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
Comments
Comments are closed.